Finding hope by expanding the frontiers of therapy
We design ground-breaking therapies through precision-targeting of membrane receptors to bring hope to people living with autoimmune diseases
Latest News
Dr. Anthony JohnsonNew Board Member
Anthony Johnson, MBBS, MD has been appointed to the Company’s Board of Directors…
Fireside Chat at the BTIG Ophthalmology Conference
Philippe Douville, Find’s Chief Executive Officer and Robert Glanzman, Find’s Chief Medical Officer will participate…
Robert Glanzman,
Chief Medical Officer
Board-certified neurologist and Fellow of the American Academy of Neurology with over 20 years experience…